The Drug Discovery World Podcast
Drug Discovery World (DDW)
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years. DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go. In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informatics; personalised medicine; screening; therapeutics, and much more. For the podcast we have selected recent, relevant and popular scientific articles, so that you can listen to all of the best content from Drug Discovery World. We hope you enjoy.
Kategorier: Hälsa
Lyssna på det sista avsnittet:
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.
In this episode, Megan Thomas is in conversation with Steve Worland, CEO of eFFECTOR. eFFECTOR is a company targeting three distinct targets central to the eIF4F translation initiation complex: MNK, eIF4A and eIF4E. Each of these targets regulates distinct sets of genes in cancer and immune cells.
Dr Worland has significant experience as a scientist and C-suite level executive/entrepreneur, and today speaks about how Selective Translation Regulator Inhibitors (STRIs) are unique to other cancer treatments, the future of the industry as well as the significance of pharma collaboration in the development process.
You can find the Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
Tidigare avsnitt
-
309 - Selective Translation Regulator Inhibitors: Depriving cancer of what it needs Mon, 29 Apr 2024 - 0h
-
308 - DDW Highlights: 29 April 2024 Mon, 29 Apr 2024 - 0h
-
307 - A look behind the scenes of the drug discovery industry Thu, 25 Apr 2024 - 0h
-
306 - DDW Highlights: 22 April 2024 Mon, 22 Apr 2024 - 0h
-
305 - DDW Highlights: 15 April 2024 Mon, 15 Apr 2024 - 0h
-
304 - DDW Highlights: 2 April 2024 Tue, 02 Apr 2024 - 0h
-
303 - Flow cytometry for drug discovery research Wed, 20 Mar 2024 - 0h
-
302 - DDW Highlights: 18 March 2024 Mon, 18 Mar 2024 - 0h
-
301 - Exploring the potential of a new class of drug candidates Tue, 12 Mar 2024 - 0h
-
300 - DDW Highlights: 11 March 2024 Mon, 11 Mar 2024 - 0h
-
299 - What trends will speed up the journey from clinic to bedside? Thu, 29 Feb 2024 - 0h
-
298 - DDW Highlights: 26 February 2024 Mon, 26 Feb 2024 - 0h
-
297 - Unlock the potential of complex human liver data Wed, 21 Feb 2024 - 0h
-
296 - DDW Highlights: 19 February 2024 Mon, 19 Feb 2024 - 0h
-
295 - DDW Events SLAS2024: Solving the diagnostic odyssey with multi-omics Thu, 08 Feb 2024 - 0h
-
294 - DDW Events SLAS2024: The building blocks of AI success stories Wed, 07 Feb 2024 - 0h
-
293 - DDW Events SLAS2024: Connecting academia, industry and the public Tue, 06 Feb 2024 - 0h
-
292 - DDW Events SLAS2024: Where is the Ignite Theatre tech leading us? Mon, 05 Feb 2024 - 0h
-
291 - DDW Events SLAS2024: A welcome to SLAS 2024 Fri, 02 Feb 2024 - 0h
-
290 - DDW Highlights: 29 January 2024 Mon, 29 Jan 2024 - 0h
-
289 - A safer option to opioid pain killers Mon, 29 Jan 2024 - 0h
-
288 - DDW Highlights: 22 January 2024 Mon, 22 Jan 2024 - 0h
-
287 - Why is Europe a drug discovery epicentre? Thu, 18 Jan 2024 - 0h
-
286 - DDW Highlights: 15 January 2024 Mon, 15 Jan 2024 - 0h
-
285 - Revolutionary technology for drug discovery and development Thu, 11 Jan 2024 - 0h
-
284 - DDW Highlights: 8 January 2024 Mon, 08 Jan 2024 - 0h
-
283 - Developing novel targeted radiopharmaceuticals for cancer treatment Thu, 04 Jan 2024 - 0h
-
282 - DDW Highlights: 27 December 2023 Wed, 27 Dec 2023 - 0h
-
281 - Where is the latest innovation in neuroscience? Wed, 20 Dec 2023 - 0h
-
280 - DDW Highlights: 19 December 2023 Tue, 19 Dec 2023 - 0h
-
279 - How the tools you use impact consistency and precision in the lab Thu, 14 Dec 2023 - 0h
-
278 - DDW Highlights: 11 December 2023 Mon, 11 Dec 2023 - 0h
-
277 - DDW Highlights: 4 December 2023 Mon, 04 Dec 2023 - 0h
-
276 - Outside the box thinking for drug discovery success Thu, 30 Nov 2023 - 0h
-
275 - Drug discovery trends: From regulation to embracing AI Thu, 23 Nov 2023 - 0h
-
274 - DDW Highlights: 20 November 2023 Mon, 20 Nov 2023 - 0h
-
273 - DDW Highlights: 13 November 2023 Mon, 13 Nov 2023 - 0h
-
272 - How to solve biological mysteries Thu, 09 Nov 2023 - 0h
-
271 - DDW Highlights: 6 November 2023 Mon, 06 Nov 2023 - 0h
-
270 - DDW Highlights: 30 October 2023 Mon, 30 Oct 2023 - 0h
-
269 - Important therapies for the future of immunotherapy Thu, 26 Oct 2023 - 0h
-
268 - DDW Highlights: 23 October 2023 Mon, 23 Oct 2023 - 0h
-
267 - Drug discovery success stories Fri, 20 Oct 2023 - 0h
-
266 - Helping to Advance Precision Medicine: Sengenics i-Ome Discovery Microarrays Thu, 19 Oct 2023 - 0h
-
265 - DDW Highlights: 17 October 2023 Tue, 17 Oct 2023 - 0h
-
264 - The evolution and future of gene therapy Thu, 12 Oct 2023 - 0h
-
263 - DDW Highlights: 10 October 2023 Tue, 10 Oct 2023 - 0h
-
262 - How does the FDA Modernisation Act 2.0 impact seizure liability testing in drug discovery? Mon, 02 Oct 2023 - 0h
-
261 - DDW Highlights: 2 October 2023 Mon, 02 Oct 2023 - 0h
-
260 - Overcoming different barriers in drug discovery Thu, 28 Sep 2023 - 0h